Manufacturer copay assistance · Opdivo (J9299) · BMS
$25 per dose · Maximum benefit $25,000/year · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Opdivo — the program's cap applies against the patient share CareCost calculates.
Yes — BMS Oncology Co-Pay Assistance Program from BMS. $25 per dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$25 per dose Maximum benefit: $25,000/year. Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, government. Income limit: No income requirement.